Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Briacell Therapeutics Corp BCTX


Primary Symbol: T.BCT Alternate Symbol(s):  BCTXW

BriaCell Therapeutics Corp. is a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care. Bria-IMT, its Phase 3 lead candidate, is a patented, off-the-shelf, cell-based, targeted immunotherapy that activates the patient’s immune system to specifically kill cancer cells without harming other cells. The Company is advancing its Bria-IMT targeted immunotherapy in combination with an immune check point inhibitor (Retifanlimab) in a pivotal Phase 3 study in metastatic breast cancer. It is also developing personalized off-the-shelf immunotherapies, Bria-OTS and Bria-OTS+, which provides a platform technology to develop personalized off-the-shelf immunotherapies for numerous types of cancer, and a soluble CD80 protein therapeutic which act both as a stimulator of the immune system, as well as an immune checkpoint inhibitor. Its pipeline also includes Bria-IMT + CPI, Bria-BRES/BRES+, Bria-PROS+, Bria-LUNG+ and Bria-MEL+.


TSX:BCT - Post by User

Comment by dragshoton Jul 01, 2022 7:32am
144 Views
Post# 34795884

RE:RE:BCTX To Quickly Regain $8/share

RE:RE:BCTX To Quickly Regain $8/shareI think you're on the right track here with the 50 and 200DMA.  We now have a situation with both a falling 50 and 200.  This is a red flag for me.  I would have sold back in April when the 50 was starting to turn flat and price crashed thru the 200. Now we're in "no man's land" and currently heading into what may very well end up being shorting territory.  Just my 2 cents worth.  GL 
LondonInvest wrote:
Well, that did not turn out at all how I imagined it.  I was able to add at these low levels today.  Still think there is really good returns possible here.  I am a holder of company.  Fast Track Designation is not just granted to anyone.  We will see where we are in a year.  These levels are insane.  Essentially at cash on hand levels now.  I think small cap biotech has between 25-33% of companies trading below cash on hand.  This has never happened... ever.  Silly levels, painful to experience, but it does not take away their pipeline, early success and FDA recognition of results significance.  GL


<< Previous
Bullboard Posts
Next >>